Genworth Financial stock
GNWNYSEGenworth Financial, Inc., Financial ServicesISIN US37247D1063
59Score 59 out of 100, Neutral
Price and trend
59 / 100
Price history
−0.8% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 7.9% below it.
Since May 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 35).
The price is 21% below its 52-week high. Largest decline in 20 years: 98% (February 2007 to March 2009).
Chart figures for advanced users
- SMA 50$9.39
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$9.14
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)35
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$7.94
- The lowest closing price of the last twelve months.
- Resistance$10.60
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Genworth Financial, Inc. belongs to the Insurance (Diversified) industry (United States) and, with a market value of $3.08B, is number 38 of 43 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $6.37B (down 10.9% year on year) and earnings of $223M (down 25.4%).
- MEQIRI Score 59 out of 100 (Neutral): rank 745 of 976 in Financial Services, median 68.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Share buybacksShare count down 19% since 2020.Capital allocation 68
Weaknesses
- Earnings per share fallingDown 25.4% a year since 2021.Growth 30
- Margin fallingOperating margin 6.8%, average of the prior years 11.3% (to 2024).Profitability 50
- Revenue shrinkingRevenue down 5% a year since 2020.Growth 30
Its standout strengths are fundamentals and stability, while momentum and growth hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are strong overall.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
not measuredClosing price of 11 Nov 2026, used by the daily score.
No fair value can be calculated for this stock, so the signal follows the valuation grade.
Valuation metrics
No fair value can be calculated for this stock from the available figures.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue fell 2.7% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Operating margin
- Net margin
In fiscal 2025: operating 7%, net 4%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 22 Feb 2027in 102 days
- Last reported
- 4 Nov 2026EPS reported $0.27 (expected $0.28)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $1.100.0%
- Revenue
- $6.1B0.0%
- Earnings per share
- $1.130.0%
- Revenue
- $5.84B0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook mixed
Share price after the results: 0.0%Higher capital return expected (buybacks of $225 million to $250 million, Enact proceeds of $445 million to $485 million), but claims experience trends above plan and CareScout matches pace below the full-year target.
“Based on our approximate 81% ownership position, we now expect to receive between $445 million and $485 million from EnACT for the full year.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 6 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. 4 insiders sold, $2.98M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Genworth Financial
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
976 rated companies in Financial Services
- This company
- 59
- Sector median
- 68
Categories against the sector medianMedian of 976 companies
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Insurance (Diversified)
The next larger and next smaller companies by market value
- Sunshine Insurance Group6963.HK $5.42B65
- White Mountains Insurance GroupWTM $5.39B76
- Porto SeguroPSSA3.SA $5.3B76
- Alm. BrandALMB.CO $3.54B63
- Vaudoise Assurances HoldingVAHN.SW $2.64B60
- Pelagos Insurance CapitalPLGO $2.31B84
- NÜRNBERGER Beteiligungs-AGNBG6.DE $1.58B39
- Exzeo GroupXZO $1.44B65
ETFs that hold Genworth Financial
Held by 15 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares Ageing Population UCITS ETF2B77 | 0.30% | 0.40% | €807M |
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.20% | 0.30% | €2.28B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.20% | 0.30% | €944.34M |
Show 5 more
| Avantis Global Small Cap Value UCITS ETFAVWS | 0.19% | 0.39% | €1.47B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.11% | 0.30% | €4.22B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.11% | 0.30% | €2.17B |
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.11% | 0.30% | €185.82M |
| Invesco Global Buyback Achievers UCITS ETFBBCK | 0.05% | 0.39% | €188.08M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 6 Nov 2026)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.